Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma 31/03/2014
Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma.
If you are interested in taking part in a clinical trial, please call us at 935 950 155 and we will assess whether you are eligible. Further information on trials at research projects
Author
Доктор Silvia Freixes, M.D.
Номер лицензии COMB: 30.762
Врач Офтальмолог
Специалист по Глаукоме
01/01/2015
FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration
19/03/2014
Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
31/03/2014
Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD
20/12/2014
MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration
